Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

321
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
321
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

231
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

217
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

820
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
820

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis.

The New England journal of medicine·2026
Same author

Structural Cardiac Abnormalities, Ventricular Dysfunction Phenotypes, and Heart Failure Risk among Antiretroviral Therapy-treated People Living with HIV in South Africa.

medRxiv : the preprint server for health sciences·2026
Same author

Microbial product translocation and mortality in adults hospitalised with HIV-associated tuberculosis: a prospective observational cohort study.

Research square·2026
Same author

Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis-endemic setting.

HemaSphere·2026
Same author

Contemporary Disengagement From Antiretroviral Therapy in the Western Cape, South Africa: A Cross-Sectional Study.

Journal of the International AIDS Society·2026
Same author

HIV-Associated Tuberculosis in Adults: Diagnosis and Clinical Management.

Cold Spring Harbor perspectives in medicine·2026

Related Experiment Video

Updated: Jun 22, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K

Post-tuberculosis treatment paradoxical reactions.

Sabine M Hermans1,2, Onno W Akkerman3,4, Graeme Meintjes5,6,7

  • 1Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Public Health-Global Health, Amsterdam Infection and Immunity, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands. s.m.hermans@amsterdamumc.nl.

Infection
|July 2, 2024
PubMed
Summary

Paradoxical reactions (PR) after tuberculosis (TB) treatment can occur, especially in lymph node TB. Differentiating post-treatment PR from relapse is key for appropriate management, often involving anti-inflammatory treatment.

Keywords:
Lymph nodeParadoxical reactionParadoxical responseParadoxical upgradingRecurrenceTuberculosis

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

218

Related Experiment Videos

Last Updated: Jun 22, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

218

Area of Science:

  • Immunology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during therapy but can also manifest after treatment completion.
  • Distinguishing post-treatment PR from microbiological relapse is crucial for patient management.
  • Literature on post-treatment PR is limited, necessitating further synthesis and understanding.

Purpose of the Study:

  • To synthesize existing literature on the epidemiology, diagnosis, and management of paradoxical reactions occurring after tuberculosis treatment.
  • To provide insights into differentiating post-treatment PR from TB relapse.
  • To report on the incidence and characteristics of post-treatment PR.

Main Methods:

  • Systematic literature search of published studies on post-treatment paradoxical reactions.
  • Synthesis of data from 30 studies, including case vignettes.
  • Focus on epidemiology, diagnosis, and management strategies.

Main Results:

  • The majority of reported post-treatment PR cases involved lymph node TB (LN-TB) and central nervous system TB (CNS-TB).
  • Incidence of post-treatment PR in LN-TB ranged from 3-14%, exceeding relapse rates in this group.
  • Post-treatment PR typically occurred within 6 months of treatment completion but could appear years later.

Conclusions:

  • Negative mycobacterial cultures are crucial for diagnosing post-treatment PR.
  • Anti-inflammatory treatment is the mainstay for managing post-treatment PR.
  • Observation is recommended for suspected post-treatment PR in LN-TB, while CNS-TB cases require prompt investigation and treatment.